Financial Counselors Inc Grifols Sa Transaction History

Financial Counselors Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$15.4 - $20.16 $157,865 - $206,660	-10,251 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$18.24 - $21.45 $17,017 - $20,012	-933 Reduced 8.34%	10,251 $187,000
Q1 2020 Apr 23, 2020	SELL	$16.28 - $25.63 $716 - $1,127	-44 Reduced 0.39%	11,184 $225,000
Q4 2019 Jan 31, 2020	SELL	$19.57 - $23.52 $19,080 - $22,932	-975 Reduced 7.99%	11,228 $262,000
Q3 2019 Nov 08, 2019	SELL	$19.85 - $22.76 $12,366 - $14,179	-623 Reduced 4.86%	12,203 $245,000

Q2 2019 Aug 14, 2019	SELL	$17.59 - $21.1 $2,321 - $2,785	-132 Reduced 1.02%	12,826 $271,000
Q1 2019 May 10, 2019	SELL	$18.01 - $20.11 $16,551 - $18,481	-919 Reduced 6.62%	12,958 $261,000
Q4 2018 Feb 01, 2019	SELL	$17.44 - $21.53 $41,053 - $50,681	-2,354 Reduced 14.5%	13,877 $255,000
Q3 2018 Oct 30, 2018	BUY	$19.97 - $21.96 $359 - $395	18 Added 0.11%	16,231 $347,000
Q2 2018 Aug 03, 2018	SELL	$20.16 - $24.68 $1,290 - $1,579	-64 Reduced 0.39%	16,213 $349,000
Q1 2018 Apr 26, 2018	BUY	$20.31 - $24.95 $304 - $374	15 Added 0.09%	16,277 $345,000
Q3 2017 Nov 13, 2017	BUY	$20.07 - $21.89 $2,247 - $2,451	112 Added 0.69%	16,262 $356,000
Q2 2017 Aug 10, 2017	BUY	N/A	16,150	16,150 $341,000

150

140M

3.54M

919K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $4.43B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Financial Counselors Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Counselors Inc with notifications on news.